Credit Suisse Ag Alaunos Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $124,346 - $376,073	-303,285 Reduced 100.0%	12 $0
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $6,682 - $12,611	10,779 Added 3.68%	303,297 $198,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $168,697 - $292,511	154,768 Added 112.35%	292,518 $319,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $10,419 - $19,754	7,236 Added 5.54%	137,750 $250,000
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $76,217 - $106,356	-28,980 Reduced 18.17%	130,514 $345,000
Q1 2021 May 14, 2021	SELL	$2.82 - $5.6 $436,299 - $866,409	-154,716 Reduced 49.24%	159,494 $574,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $24,898 - $36,811	-11,913 Reduced 3.65%	314,210 $791,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $3.43 $42,792 - $61,414	17,905 Added 5.81%	326,123 $822,000
Q2 2020 Aug 12, 2020	BUY	$2.2 - $3.71 $178,618 - $301,214	81,190 Added 35.76%	308,218 $1.01 Million
Q1 2020 May 13, 2020	BUY	$1.9 - $4.98 $45,594 - $119,505	23,997 Added 11.82%	227,028 $556,000
Q4 2019 Feb 12, 2020	BUY	$3.95 - $5.35 $1,690 - $2,289	428 Added 0.21%	203,031 $957,000
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $418,071 - $702,522	101,228 Added 99.85%	202,603 $867,000
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $44,464 - $69,266	11,172 Added 12.39%	101,375 $591,000
Q1 2019 May 14, 2019	BUY	$2.0 - $4.4 $4,610 - $10,142	2,305 Added 2.62%	90,203 $346,000
Q4 2018 Feb 13, 2019	BUY	$1.61 - $3.62 $22,248 - $50,024	13,819 Added 18.65%	87,898 $164,000
Q3 2018 Nov 13, 2018	SELL	$2.26 - $3.27 $85,075 - $123,095	-37,644 Reduced 33.69%	74,079 $237,000
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $68,970 - $112,819	-22,838 Reduced 16.97%	111,723 $338,000
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $104,647 - $155,459	30,245 Added 28.99%	134,561 $527,000
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $241,828 - $395,388	-60,457 Reduced 36.69%	104,316 $432,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $216,800 - $285,446	43,447 Added 35.81%	164,773 $1.01 Million
Q2 2017 Aug 14, 2017	BUY	N/A	121,326	121,326 $755,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account